“A pilot study of chromosomal aberrations and epigenetic changes in peripheral blood samples to identify patients with melanoma” available in Melanoma Research, 2015.
OBD collaborative work with the Mayo Clinic on the successful validation of a melanoma EpiSwitch™ signature has been published in Melanoma Research.
July 28, 2015
|In Publications